Iron Deficiency in Patients With Nonalcoholic Fatty Liver Disease Is Associated With Obesity, Female Gender, and Low Serum Hepcidin

BACKGROUND & AIMS: Iron deficiency is often observed in obese individuals. The iron regulatory hormone hepcidin is regulated by iron and cytokines interleukin (IL) 6 and IL1 beta. We examine the relationship between obesity, circulating levels of hepcidin, and IL6 and IL1 beta, and other risk factors in patients with nonalcoholic fatty liver disease (NAFLD) with iron deficiency. METHODS: We collected data on 675 adult subjects (> 18 years old) enrolled in the Nonalcoholic Steato-hepatitis Clinical Research Network. Subjects with transferrin saturation < 20% were categorized as iron deficient, whereas those with transferrin saturation 20% were classified as iron normal. We assessed clinical, demographic, anthropometric, laboratory, dietary, and histologic data from patients, and serum levels of hepcidin and cytokines IL6 and IL1 beta. Univariate and multivariate analysis were used to identify risk factors for iron deficiency. RESULTS: One-third of patients (231 of 675; 34%) were iron deficient. Obesity, diabetes, and metabolic syndrome were more common in subjects with iron deficiency (P < .01), compared with those that were iron normal. Serum levels of hepcidin were significantly lower in subjects with iron deficiency (61 +/- 45 vs 81 +/- 51 ng/mL; P < .0001). Iron deficiency was significantly associated with female gender, obesity, increased body mass index and waist circumference, presence of diabetes, lower alcohol consumption, black or American Indian/Alaska Native race (P <= .018), and increased levels of IL6 and IL1 beta (6.6 vs 4.8 for iron normal, P <= .0001; and 0.45 vs 0.32 for iron normal, P <= .005). CONCLUSIONS: Iron deficiency is prevalent in patients with NAFLD and associated with female gender, increased body mass index, and nonwhite race. Serum levels of hepcidin were lower in iron-deficient subjects, reflecting an appropriate physiologic response to decreased circulating levels of iron, rather than a primary cause of iron deficiency in the setting of obesity and NAFLD.